BEAT HeartBeam, Inc.

CIK 0001779372 12 ready 8-Ks latest April 16, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 12

Latest filing April 16, 2026, 7:59 PM ET

Top materiality 0.75

Event mix other_material ×6 · leadership ×4 · regulatory ×1

Sentiment 1 pos · 3 neg · 8 neu

Executive change recent →

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for BEAT

Highest-materiality recent filing

HeartBeam receives FDA NSE letter for 12-Lead ECG Synthesis 510(k), will seek resolution

November 21, 2025, 6:59 PM ET regulatory materiality 0.75 negative item 8.01

FDA issued a Not Substantially Equivalent (NSE) letter for HeartBeam's 12-Lead ECG Synthesis Software 510(k) on Nov 20, 2025.
Company stands behind its clinical data and will work with FDA to resolve the NSE determination.

Read filing →

April 16, 2026, 7:59 PM ET other material materiality 0.65 neutral item 1.01 item 8.01 item 9.01 ◈ Material Agreements

HeartBeam closes $10M public offering of 12.5M shares at $0.80 per share

Issued 12.5M shares at $0.80, gross proceeds $10M; underwriter option for 1.875M additional shares.
November 21, 2025, 6:59 PM ET regulatory materiality 0.75 negative item 8.01

HeartBeam receives FDA NSE letter for 12-Lead ECG Synthesis 510(k), will seek resolution

FDA issued a Not Substantially Equivalent (NSE) letter for HeartBeam's 12-Lead ECG Synthesis Software 510(k) on Nov 20, 2025.
July 16, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07 item 9.01

HeartBeam shareholders approve 3M share increase to equity plan, elect directors

Shareholders voted to increase authorized shares under 2022 Equity Plan by 3M from 8.9M to 11.9M.
May 5, 2025, 7:59 PM ET leadership materiality 0.30 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change

HeartBeam CEO Robert Eno appointed to Board of Directors effective May 5, 2025

CEO Robert Eno joins Board effective May 5, 2025; Board expands from 8 to 9 members.
April 25, 2025, 7:59 PM ET other material materiality 0.60 negative item 4.01 item 9.01

HeartBeam auditor resigns; CBIZ CPAs engaged; going concern noted

Marcum LLP resigned as auditor on April 21, 2025, due to CBIZ CPAs acquiring its attest business.
February 26, 2025, 6:59 PM ET other material materiality 0.50 positive item 8.01 item 9.01

HeartBeam raises additional ~$1.5M from over-allotment exercise in public offering

Underwriter exercised over-allotment for 864,033 shares at $1.70, gross proceeds ~$1.5M.
February 18, 2025, 6:59 PM ET other material materiality 0.60 neutral item 1.01 item 8.01 item 9.01

HeartBeam prices $10M public offering of 5.88M shares at $1.70 per share

Offering of 5,882,353 shares of common stock at $1.70/share; gross proceeds ~$10M.
October 23, 2024, 7:59 PM ET leadership materiality 0.65 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change ×2

HeartBeam appoints Robert Eno as CEO; founder Vajdic moves to President

Robert Eno named CEO effective Oct 21, 2024; base salary of $400,000 with 60% incentive bonus.
September 10, 2024, 7:59 PM ET leadership materiality 0.60 neutral item 5.02 item 9.01 ◈ executive_change

HeartBeam appoints Timothy Cruickshank as CFO; base salary $385K plus equity

Timothy Cruickshank appointed CFO effective September 9, 2024.
June 18, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.07 item 9.01

HeartBeam shareholders approve 3M share increase to equity plan and elect eight directors

Shareholders approved amendment to 2022 Equity Plan, increasing authorized shares from 5.9M to 8.9M (3M increase).
May 2, 2024, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 1.02 item 9.01 ◈ Material Agreements ×2

HeartBeam enters $17M at-the-market equity facility with Public Ventures, terminates prior AGP deal

New ATM sales agreement with Public Ventures allows sale of up to $17M of common stock at 3% commission.
February 5, 2024, 6:59 PM ET leadership materiality 0.65 negative item 5.02 item 9.01 ◈ executive_change

HeartBeam CFO Richard Brounstein retires effective Feb 1, 2024; no successor named

Richard Brounstein retired as CFO effective February 1, 2024; he served since 2015.

Executive changes

Appointed

Robert Eno

Director

BEAT · HeartBeam, Inc.

Effective: 2025-05-05
Filed: May 5, 2025, 7:59 PM ET

appointed Robert Eno, the Company’s Chief Executive Officer, as a member of the Board effective as of May 5, 2025

Role change

Branislav Vajdic

President

BEAT · HeartBeam, Inc.

Effective: 2024-10-21
Filed: October 23, 2024, 7:59 PM ET

the Board appointed Branislav Vajdic, PhD, Founder and current Chief Executive Officer as President of the Company (the “President Appointment”) effective as of October 21, 2024.

Appointed

Robert Eno

Chief Executive Officer

BEAT · HeartBeam, Inc.

Effective: 2024-10-21
Filed: October 23, 2024, 7:59 PM ET

On October 17, 2024, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Robert Eno as Chief Executive Officer of the Company (the “CEO Appointment”) effective as of October 21, 2024.

Appointed

Timothy Cruickshank

Chief Financial Officer

BEAT · HeartBeam, Inc.

Effective: 2024-09-09
Filed: September 10, 2024, 7:59 PM ET

On August 22, 2024, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Timothy Cruickshank as Chief Financial Officer of the Company (the “ Appointment ”) effective as of September 9, 2024.

Departed

Richard Brounstein

Chief Financial Officer

BEAT · HeartBeam, Inc.

Effective: 2024-02-01
Filed: February 5, 2024, 6:59 PM ET

On December 29, 2023, Richard Brounstein, informed the Company of his plans to retire from his position (the “ Retirement ”) as Chief Financial Officer of HeartBeam, Inc. (the “ Company ” or " HeartBeam ") effective as of February 1, 2024.

Materiality & sentiment trend

Max materiality 0.75 · Median 0.60 · Most common event other_material

1 positive 3 negative 8 neutral

source · BEAT on sec.gov